EDSA
Price
$2.45
Change
+$0.13 (+5.60%)
Updated
Apr 2 closing price
Capitalization
17.13M
RNAZ
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Apr 2 closing price
Capitalization
367.97K
Ad is loading...

EDSA vs RNAZ

Header iconEDSA vs RNAZ Comparison
Open Charts EDSA vs RNAZBanner chart's image
Edesa Biotech
Price$2.45
Change+$0.13 (+5.60%)
Volume$20.57K
Capitalization17.13M
TransCode Therapeutics
Price$0.53
Change-$0.01 (-1.85%)
Volume$4.06M
Capitalization367.97K
EDSA vs RNAZ Comparison Chart
Loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDSA vs. RNAZ commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a StrongBuy and RNAZ is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (EDSA: $2.45 vs. RNAZ: $0.53)
Brand notoriety: EDSA and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 1% vs. RNAZ: 41%
Market capitalization -- EDSA: $17.13M vs. RNAZ: $367.97K
EDSA [@Biotechnology] is valued at $17.13M. RNAZ’s [@Biotechnology] market capitalization is $367.97K. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, RNAZ is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 4 TA indicator(s) are bullish while RNAZ’s TA Score has 2 bullish TA indicator(s).

  • EDSA’s TA Score: 4 bullish, 3 bearish.
  • RNAZ’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, EDSA is a better buy in the short-term than RNAZ.

Price Growth

EDSA (@Biotechnology) experienced а -3.45% price change this week, while RNAZ (@Biotechnology) price change was -10.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.69%. For the same industry, the average monthly price growth was -9.74%, and the average quarterly price growth was -14.08%.

Reported Earning Dates

EDSA is expected to report earnings on Dec 13, 2023.

RNAZ is expected to report earnings on May 23, 2023.

Industries' Descriptions

@Biotechnology (-7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDSA($17.1M) has a higher market cap than RNAZ($368K). EDSA YTD gains are higher at: 45.833 vs. RNAZ (-84.318). EDSA has higher annual earnings (EBITDA): -5.99M vs. RNAZ (-14.33M). RNAZ has more cash in the bank: 1.88M vs. EDSA (1.56M). EDSA has less debt than RNAZ: EDSA (0) vs RNAZ (152K). EDSA (0) and RNAZ (0) have equivalent revenues.
EDSARNAZEDSA / RNAZ
Capitalization17.1M368K4,647%
EBITDA-5.99M-14.33M42%
Gain YTD45.833-84.318-54%
P/E RatioN/A0.00-
Revenue00-
Total Cash1.56M1.88M83%
Total Debt0152K-
FUNDAMENTALS RATINGS
EDSA: Fundamental Ratings
EDSA
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDSARNAZ
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARS51.492.57
+5.25%
Tarsus Pharmaceuticals
AVAH5.620.16
+2.93%
Aveanna Healthcare Holdings
SRL8.290.23
+2.87%
Scully Royalty Ltd
ASND152.150.72
+0.47%
Ascendis Pharma A/S
ONBPP25.020.06
+0.26%
Old National Bancorp

EDSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with DOMH. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then DOMH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
+5.60%
DOMH - EDSA
36%
Loosely correlated
+0.51%
MBRX - EDSA
35%
Loosely correlated
+0.20%
ENTA - EDSA
33%
Poorly correlated
-0.38%
SNPX - EDSA
33%
Poorly correlated
-2.56%
ORMP - EDSA
32%
Poorly correlated
+3.29%
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-2.29%
NGNE - RNAZ
48%
Loosely correlated
+8.34%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+1.87%
EDSA - RNAZ
31%
Poorly correlated
+5.60%
More